Grail, Inc. Attracts New Institutional Investment as Stock Volatility Persists Envestnet Asset Management recently purchased nearly 19,000 shares of Grail, Inc., valued at $337,000, marking a notable new position. Other institutional investors have also increased their stakes. Despite this, Grail shares have experienced a 6% decline, reflecting ongoing volatility in the biotech sector.3